1 Min Read
April 11 (Reuters) - Abivax SA:
* Announces expansion of its portfolio of antiviral drug candidates with a program for treatment of Zika Virus infections Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.